ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ICU MEDICAL INC/DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$161.24−1.75 (-1.07%)
Close on Oct 19, 2026
- Market cap
- $4.04B
- P/E (TTM)
- 134.4
- Dividend yield
- –
Icu Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Icu Medical | Industry median |
|---|---|---|
| Market Cap | $4.03B | $229.23M |
| Enterprise Value | $4.97B | $194.73M |
| PE Ratio | 134.37 | 33.41 |
| PS Ratio | 1.87 | 3.14 |
| PB Ratio | 1.87 | 3.19 |
| P/TBV Ratio | 40.40 | 4.69 |
| P/FCF Ratio | 26.38 | 27.25 |
| P/OCF Ratio | 17.06 | 22.23 |
Enterprise value
| Measure | Icu Medical | Industry median |
|---|---|---|
| EV / Sales | 2.30 | 2.93 |
| EV / EBITDA | 18.16 | 19.97 |
| EV / EBIT | 68.90 | 25.47 |
| EV / FCF | 32.49 | 27.85 |
Income (trailing twelve months)
| Measure | Icu Medical | Industry median |
|---|---|---|
| Revenue | $2.16B | $102.39M |
| Gross Profit | $845.15M | $60.36M |
| Operating Income | $72.06M | -$4.31M |
| Pretax Income | $754.00K | -$2.26M |
| Net Income | $30.09M | -$6.57M |
| EBITDA | $273.33M | -$1.98M |
| EPS (Diluted) | $1.20 | -$0.07 |
Margins
| Measure | Icu Medical | Industry median |
|---|---|---|
| Gross Margin | 39.1% | 55.1% |
| Operating Margin | 3.34% | -6.04% |
| Pretax Margin | 0.03% | -4.11% |
| Profit Margin | 1.39% | -10.5% |
| EBITDA Margin | 12.7% | -2.67% |
| FCF Margin | 7.08% | -0.30% |
Returns
| Measure | Icu Medical | Industry median |
|---|---|---|
| Return on Equity (ROE) | 1.41% | -19.2% |
| Return on Assets (ROA) | 0.74% | -13.3% |
| Return on Invested Capital (ROIC) | 2.31% | -4.11% |
| Return on Capital Employed (ROCE) | 2.07% | -9.07% |
Growth
| Measure | Icu Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -8.97% | 8.85% |
| FCF Growth (YoY) | 152.5% | 10.6% |
| Revenue Growth (3Y CAGR) | -0.72% | 7.08% |
| Revenue Growth (5Y CAGR) | 11.9% | 11.8% |
| EPS Growth (5Y CAGR) | -62.5% | 7.64% |
Balance sheet
| Measure | Icu Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $298.30M | $37.33M |
| Total Debt | $1.23B | $72.66M |
| Net Cash (Debt) | -$932.90M | $3.92M |
| Net Cash Per Share | -$37.31 | $0.28 |
| Equity (Book Value) | $2.15B | $57.36M |
| Book Value Per Share | $86.05 | $2.81 |
| Tangible Book Value | $99.80M | $10.71M |
| Working Capital | $712.54M | $54.64M |
Financial position
| Measure | Icu Medical | Industry median |
|---|---|---|
| Current Ratio | 2.43 | 2.50 |
| Quick Ratio | 0.97 | 1.54 |
| Debt / Equity | 0.57 | 0.38 |
| Debt / EBITDA | 4.50 | 2.31 |
| Debt / FCF | 8.06 | 3.50 |
| Net Debt / EBITDA | 3.41 | 1.53 |
| Interest Coverage | 0.87 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Icu Medical | Industry median |
|---|---|---|
| Operating Cash Flow | $236.37M | -$653.46K |
| Capital Expenditures | -$83.54M | -$3.69M |
| Free Cash Flow | $152.83M | -$835.02K |
| FCF Per Share | $6.11 | -$0.02 |
Efficiency
| Measure | Icu Medical | Industry median |
|---|---|---|
| Asset Turnover | 0.53 | 0.59 |
| Inventory Turnover | 2.15 | 2.21 |
| Revenue Per Employee | $166.12K | $322.75K |
| Profits Per Employee | $2.31K | -$52.11K |
| Employee Count | 13,000 | 197 |
Dividends and yields
| Measure | Icu Medical | Industry median |
|---|---|---|
| Earnings Yield | 0.75% | -6.92% |
| FCF Yield | 3.79% | -0.62% |
Shares
| Measure | Icu Medical | Industry median |
|---|---|---|
| Shares Outstanding | 25,007,000 | 44,856,700 |
| Shares Change (YoY) | 2.04% | 3.35% |
| Shares Change (QoQ) | 0.06% | 0.27% |
| Float | 24,564,500 | 36,934,400 |
| Shares Held by Insiders | 1.77% | 10.6% |
| Shares Held by Institutions | 104.2% | 63.5% |
Taxes
| Measure | Icu Medical | Industry median |
|---|---|---|
| Income Tax | -$30.96M | $1.52M |
| Effective Tax Rate | -4105.4% | 18.6% |
Scores
| Measure | Icu Medical | Industry median |
|---|---|---|
| Graham Number | $48.20 | $34.37 |
| Graham Upside | -70.1% | -58.3% |
| Altman Z-Score | 2.41 | 1.95 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -2.65 | -2.64 |
Calculated by StockData from Icu Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.